Jumonji Demethylase Inhibitor GSK-J4 treated Multiple Myeloma JJN3 and RPMI

ABSTRACT: Analysis of Multiple Myeloma Cell lines JJN-3 and RPMI gene expression following treated with GSK-J4 or Bortezomib Total RNA extracted from cells after 6 or 24 hour treatment with either GSK-J4, GSK-J5, Bortezomib or vehicle

ORGANISM(S): Homo sapiens

SUBMITTER: Udo Oppermann 

PROVIDER: E-GEOD-60600 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress